Fate Therapeutics Inc. (FATE) gained 8.55% or 1.06 to $13.53. It is near 561660 shares traded, which is 64.73% compare to the average total volume 867749. The market cap of FATE is $722.49 million. The year to date change is 106.32%. The 52 week price range is from $3.8 to $16.94. Price of FATE have changed -7.77% during last week. It have changed -23.32% over last month, 42.40% over last 3 months, 23.37% over last 6 months and 170.28% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for FATE is 13.44. It is -0.67% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for FATE is 11.38. It is -15.89% below current price. The 52-week High is 16.94. It is 25.20% from the current price. The 52-week Low is 3.8. It is -71.91% from current price.
There are some statistics of FATE. It is has market cap $722.49 million. The share outstanding is 53.42 million. The average volume is 867749. The revenue is 1.03M. It has 69.21M cash and 14.79M in debt. The percent of top 15 Institution holding is 95.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of FATE is -106.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of FATE is -72.52%.